1. Stocks
    2. /
  2. CSL (ASX: CSL)
    3. /

CSL (ASX: CSL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

CSL Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • CSL (ASX: CSL)
    Latest News

    Woman in celebratory fist move looking at phone
    Broker Notes

    Citi says the CSL share price can rise 23% from here

    | James Mickleboro

    One leading broker sees a lot of upside for this biotherapeutics giant.

    Read more »

    Woman on her laptop thinking to herself.
    Healthcare Shares

    This director is buying the dip on CSL shares. Should you?

    | Bronwyn Allen

    The ASX 200 healthcare giant has lost 14% of its market capitalisation since mid-June.

    Read more »

    A miner in a hardhat makes a sale on his tablet in the field.
    Investing Strategies

    Expert names his 'preferred lithium company' plus an oversold ASX 200 stock to buy

    | Tony Yoo

    Here is a pair of shares that Shaw and Partners' Jed Richards says are bargains at the moment.

    Read more »

    a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
    Blue Chip Shares

    Here are 3 ASX 200 blue chip shares to buy right now

    | James Mickleboro

    Brokers say that these could be the blue chip shares to strengthen your portfolio right now.

    Read more »

    Broker written in white with a man drawing a yellow underline.
    Broker Notes

    Top brokers name 3 ASX shares to buy next week

    | James Mickleboro

    Brokers gave the thumbs up to these ASX shares last week. Here's why they are bullish on them.

    Read more »

    A woman's hair is blown back and her face is in shock at this big news.
    Earnings Results

    3 ASX shares that delivered surprise results last week

    | James Mickleboro

    These ASX shares delivered surprisingly good results last week.

    Read more »

    A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
    Broker Notes

    Top brokers name 3 ASX shares to buy today

    | James Mickleboro

    Technology, lithium, and plasma therapies are on the menu this week.

    Read more »

    A health professional wearing a stethoscope and scrubs shrugs with uncertainty.
    Healthcare Shares

    Results in! What are brokers saying about the CSL share price?

    | James Mickleboro

    Are CSL shares a post-results buy? Let's find out what brokers are saying.

    Read more »

    Woman on her laptop thinking to herself.
    How to invest

    Turning a monthly investment in ASX shares into a $200k portfolio (in less than 10 years)

    | James Mickleboro

    Here's a three-step plan to growing a $200,000 investment portfolio.

    Read more »

    Top ten gold trophy.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    We saw some huge moves higher on the ASX 200 this Tuesday.

    Read more »

    A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
    Share Market News

    ASX 200 lifts on latest wages, RBA comments

    | Mitchell Lawler

    Could this instalment of wage growth data be setting the scene for another month without an interest rate rise?

    Read more »

    A man clenches his fists in excitement as gold coins fall from the sky.
    Share Gainers

    Why Cochlear, CSL, Life360, and Pro Medicus shares are racing higher

    | James Mickleboro

    These ASX shares are having a strong session on Tuesday.

    Read more »

    Frequently Asked Questions

    CSL was listed on the ASX in June 1994.

    CSL has paid twice yearly dividends every year since late 1997, a little over three years after the company’s initial listing on the ASX. Up until early 2005, CSL’s dividends were all fully franked. Since then, franking credits have been intermittent.

    Since 2021 CSL has paid an unfranked interim dividend in April and a 10% franked final dividend in September/October.

    CSL has a dividend reinvestment plan, however, it has not been active since 2004. Instead, CSL periodically executes share buybacks as a way of delivering additional returns for shareholders.

    CSL originally floated in 1994 at $2.30 per share. However, taking into account share buybacks, the adjusted entry price is equivalent to around 76 cents. 

    CSL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About CSL

    CSL Limited (ASX: CSL) is an Australian-based global biotechnology company that develops and delivers biotherapies and vaccines to protect public health and help people with life-threatening medical conditions live full lives.

    CSL has been in operation for more than a century and was listed on the ASX in 1994. Today, the blue-chip healthcare company is one of the largest on the ASX.

    CSL’s operational businesses include CSL Behring, CSL Seqirus and CSL Vifor. Its Plasma business operates one of the largest plasma collection networks in the world. CSL is recognised for its global leadership in three main areas: rare and serious diseases, vaccine development, and iron deficiency and nephrology (kidney research).

    The company operates in over 40 countries, predominantly Australia, the United States, Germany, the United Kingdom, and Switzerland.

     

    Profile

    since

    Note